
News from BusinessCloud.co.uk
Top BusinessCloud.co.uk News

Business · FranceFrench pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1.15 billion, expanding its respiratory vaccine portfolio. Following the acquisition, Vicebio's non-mRNA candidate vaccine for treating respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) will be added to Sanofi's range.See the Story
France's Sanofi to acquire biotech firm Vicebio for $1.15 billion
84% Center coverage: 13 sources